Minerva Imaging
PrivateLast Round
Growth Equity
Jun 10, 2025
Momentum Score
25 /100
Company Overview
Minerva Imaging is a biotechnology company that operates as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) specializing in targeted radiopharmaceuticals and molecular imaging for drug development.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minerva Imaging Comps
Public and private peers based on sector, stage, and business model.
Minerva Imaging Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jun 10, 2025 |
Key People
Founding team and executive leadership
Minerva Imaging Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Grew 20% QoQ, from 164 to 197 employees.
- Jun 10, 2025
Nordic Capital led the round.
Minerva Imaging Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Minerva Imaging's valuation, stock price, and market status.
